AVDL

Avadel Pharmaceuticals
AVDL

Overview Fund Activity

71 hedge funds and large institutions have $332M invested in Avadel Pharmaceuticals in 2014 Q3 according to their latest regulatory filings, with 13 funds opening new positions, 21 increasing their positions, 25 reducing their positions, and 6 closing their positions.

Holders
71
Holders Change
+7
Holders Change %
+10.94%
% of All Funds
2.06%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.09%
New
13
Increased
21
Reduced
25
Closed
6
Calls
$1.45M
Puts
$611K
Net Calls
+$840K
Net Calls Change
+$3.4M

Top Buyers

1
T. Rowe Price Associates
1
T. Rowe Price Associates
Maryland
$6.61M
2
PC
2
PointState Capital
New York
$5.72M
3
KCM
3
Kennedy Capital Management
Missouri
$14.8M
4
TI
4
Turner Investments
Pennsylvania
$6.77M
5
Morgan Stanley
5
Morgan Stanley
New York
$6.31M

Top Sellers

1
CCM
1
Consonance Capital Management
New York
$0
2
BC
2
Broadfin Capital
New York
$71.6M
3
PA
3
Perceptive Advisors
New York
$8.73M
4
Millennium Management
4
Millennium Management
New York
$9.08M
5
Jennison Associates
5
Jennison Associates
New York
$10.2M
Name Holding Trade Value Shares
Change 		Shares
Change %
Jane Street
76
Jane Street
New York
– -$278K -18,523 Closed
WAM
77
Wolverine Asset Management
Illinois
– -$90K -6,002 Closed
1 2 3
4